| Product Code: ETC7658236 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel continued to see a high concentration of import shipments of pegylated proteins, with top exporting countries including Switzerland, USA, Germany, China, and Belgium. Despite a negative compound annual growth rate (CAGR) of -13.88% from 2020 to 2024, there was a positive growth rate of 8.63% from 2023 to 2024. The high Herfindahl-Hirschman Index (HHI) indicates a significant level of market concentration, suggesting that these top exporting countries have a strong presence in Israel`s pegylated proteins market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel PEGylated Proteins Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel PEGylated Proteins Market Revenues & Volume, 2022 & 2032F |
3.3 Israel PEGylated Proteins Market - Industry Life Cycle |
3.4 Israel PEGylated Proteins Market - Porter's Five Forces |
3.5 Israel PEGylated Proteins Market Revenues & Volume Share, By Product & Services, 2022 & 2032F |
3.6 Israel PEGylated Proteins Market Revenues & Volume Share, By Protein Type, 2022 & 2032F |
3.7 Israel PEGylated Proteins Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Israel PEGylated Proteins Market Revenues & Volume Share, By End-user, 2022 & 2032F |
4 Israel PEGylated Proteins Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Israel leading to higher demand for pegylated proteins. |
4.2.2 Technological advancements in the development and production of pegylated proteins. |
4.2.3 Growing investments in research and development activities in the biopharmaceutical sector in Israel. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and commercialization of pegylated proteins in Israel. |
4.3.2 High costs associated with the development and manufacturing of pegylated proteins. |
4.3.3 Limited awareness and understanding among healthcare professionals and patients about the benefits of pegylated proteins. |
5 Israel PEGylated Proteins Market Trends |
6 Israel PEGylated Proteins Market, By Types |
6.1 Israel PEGylated Proteins Market, By Product & Services |
6.1.1 Overview and Analysis |
6.1.2 Israel PEGylated Proteins Market Revenues & Volume, By Product & Services, 2022 - 2032F |
6.1.3 Israel PEGylated Proteins Market Revenues & Volume, By Consumables, 2022 - 2032F |
6.1.4 Israel PEGylated Proteins Market Revenues & Volume, By Services, 2022 - 2032F |
6.2 Israel PEGylated Proteins Market, By Protein Type |
6.2.1 Overview and Analysis |
6.2.2 Israel PEGylated Proteins Market Revenues & Volume, By Colony-stimulating Factor, 2022 - 2032F |
6.2.3 Israel PEGylated Proteins Market Revenues & Volume, By Interferons, 2022 - 2032F |
6.2.4 Israel PEGylated Proteins Market Revenues & Volume, By Erythropoietin, 2022 - 2032F |
6.2.5 Israel PEGylated Proteins Market Revenues & Volume, By Recombinant Factor VII, 2022 - 2032F |
6.2.6 Israel PEGylated Proteins Market Revenues & Volume, By Others, 2022 - 2032F |
6.3 Israel PEGylated Proteins Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Israel PEGylated Proteins Market Revenues & Volume, By Cancer, 2022 - 2032F |
6.3.3 Israel PEGylated Proteins Market Revenues & Volume, By Autoimmune Diseases, 2022 - 2032F |
6.3.4 Israel PEGylated Proteins Market Revenues & Volume, By Hepatitis, 2022 - 2032F |
6.3.5 Israel PEGylated Proteins Market Revenues & Volume, By Multiple Sclerosis, 2022 - 2032F |
6.3.6 Israel PEGylated Proteins Market Revenues & Volume, By Hemophilia, 2022 - 2032F |
6.3.7 Israel PEGylated Proteins Market Revenues & Volume, By Gastrointestinal Disorders, 2022 - 2032F |
6.4 Israel PEGylated Proteins Market, By End-user |
6.4.1 Overview and Analysis |
6.4.2 Israel PEGylated Proteins Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2022 - 2032F |
6.4.3 Israel PEGylated Proteins Market Revenues & Volume, By Contract Research Organizations, 2022 - 2032F |
6.4.4 Israel PEGylated Proteins Market Revenues & Volume, By Academic & Research Institutes, 2022 - 2032F |
7 Israel PEGylated Proteins Market Import-Export Trade Statistics |
7.1 Israel PEGylated Proteins Market Export to Major Countries |
7.2 Israel PEGylated Proteins Market Imports from Major Countries |
8 Israel PEGylated Proteins Market Key Performance Indicators |
8.1 Research and development expenditure in the biopharmaceutical sector in Israel. |
8.2 Number of clinical trials involving pegylated proteins conducted in Israel. |
8.3 Adoption rate of pegylated proteins in the treatment of chronic diseases in Israel. |
8.4 Number of patents filed for new technologies related to pegylated proteins in Israel. |
8.5 Rate of collaborations and partnerships between Israeli biopharmaceutical companies and international organizations for pegylated protein development. |
9 Israel PEGylated Proteins Market - Opportunity Assessment |
9.1 Israel PEGylated Proteins Market Opportunity Assessment, By Product & Services, 2022 & 2032F |
9.2 Israel PEGylated Proteins Market Opportunity Assessment, By Protein Type, 2022 & 2032F |
9.3 Israel PEGylated Proteins Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 Israel PEGylated Proteins Market Opportunity Assessment, By End-user, 2022 & 2032F |
10 Israel PEGylated Proteins Market - Competitive Landscape |
10.1 Israel PEGylated Proteins Market Revenue Share, By Companies, 2025 |
10.2 Israel PEGylated Proteins Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here